ULK1 was a promising therapeutic target within the autophagy framework, ULK1/Beclin‐1 initiation complex act as targeted autophagy modulation as a revolutionary pathway for developing more effective and personalised interventions for depressive disorders [22]. Here, BECN1 is linked to depressive disorder.